Cite
HARVARD Citation
Yamanishi, K. et al. (2013). THU0223 The Novel CPLA2 Inhibitor AK106-001616 is a New Category of Anti-Inflammatory/Analgesic Drug Demonstrating Efficacy and Favorable Tolerability in the Treatment of Rheumatoid Arthritis. Annals of the rheumatic diseases. p. A240. [Online].